Martin Jacko
Company: Aperture Therapeutics
Job title: Chief Executive Officer
Seminars:
Embracing Genetic Diversity of iPSC-based Neuroinflammation Models for Robust Drug Discovery 12:10 pm
• Developing iPSC panels to account for distinct disease origins and diverse patient genomic background in drug discovery • Leveraging data on protective genomic variants to bolster prioritization of therapeutically relevant disease modifiers • Catalyzing discovery of neuroinflammation modulators for neurodegeneration using therapeutic oligonucleotidesRead more
day: Day One